the cultured mycelium, purified by solvent extraction followed by chromatography on silica gel and then isolated as crystals (Q0H34O3, mp 108°C). Vinigrol decreased arterial blood pressure of anesthetized normotensive rats dose-dependently whenadministered intravenously. Vinigrol inhibited platelet activating factor and epinephrine induced platelet aggregation.
In the course of our search for antihypertensive compoundsof microbial origin, we reported the discovery of a very potent vasodilator, WS-1228 BDand a novel calcium channel blocker, amauromine2). Recently, the pharmacological characteristics of amauromine were studied in detail and it was established that it is a novel type of calcium channel blocker3). More recently we discovered the antihypertensive compound,vinigrol by testing culture broths using anesthetized normotensive rats. In this paper, we describe the taxonomy of the producing strain, the fermentation, the isolation and the physico-chemical and biological properties of vinigrol. Detailed studies of the biological and pharmacological characteristics of vinigrol will be discussed in a succeeding paper4).
Materials and Methods

Fermentati on
The growth of Virgaria nigra F-5408 on a mature slant culture was used to inoculate five 500-ml flasks each containing 100 ml of sterile seed mediumcomposed of corn starch 1 %, soluble starch 1 %, glucose 1 % corn steep liquor 0.5% dried yeast 0.5% cotton seed flour 0.5% and CaCO3 0.2%. The mediumwas adjusted to pH6.0 prior to the addition of CaCO3.The flasks were shaken on a rotary shaker (220 rpm, 5.1-cm throw) for 3 days at 25°C. The contents of the flasks were used to inoculate 20 liters of fermentation mediumin a 30-liter jar fermentor. The composition of the production medium was as follows: Glucose 3 %, corn steep liquor 1 %, cotton seed flour 0.5 %, gluten meal 0.5 %, soy bean meal 0.5% and dried yeast 0.5%. pH was adjusted to 6.5 and then CaCO30.2% was mixed before sterilization. Fermentation was allowed to proceed for 4 days at 25°C.
Blood Pressure and Heart Rate Measurement
Male Sprague-Dawley rats (350-400 g) were anesthetized with urethane (1 g/kg, ip). Arterial blood pressure was measured with a pressure transducer via a polyethylene catheter (PE50) that was inserted into the femoral artery. Blood pressure was recorded on a biophysiograph system 180 (Nihondenki-Sanei). The pulse pressure signal was used to trigger a tachometer for a measurement of heart rate. Active compoundpresent in a fermentation broth or in a preparation there from was JAN. 1988 detected by its hypotensive effect. To confirm the antihypertensive activity, test sample was injected intravenously through a polyethylene catheter inserted into a femoral vein.
Platelet Aggregation Test
Platelet aggregation was measured turbidimetrically with a platelet aggregation tracer (Nike Bioscience, Inc.) according to the method reported previously10. Briefly, rabbit blood was collected through a polyethylene catheter from the carotid artery of a male white Japanese rabbit into a plastic tube that contained one volumeof 3.8% sodium citrate to nine volume of blood. After obtaining platelet rich plasma by centrifugation, the platelet number was adjusted to 5 x 105 cells/mm3 with platelet poor plasma. Humanblood was collected from the antecubital vein of healthy volunteers and platelet number was adjusted to 3 x 105 cells/mm3. Platelet aggregation agents employed in this experiment were, epinephrine 0.4 mMplus ADP0.4 ptu9 platelet activating factor (PAF) 20 nM, ADP 2.5 jum, bovine thrombin 0.5 u/ml and collagen (bovine achilles tendon) 10^g/ml for rabbit platelet aggregation and epinephrine 5 jum, PAF 1.5 jum and ADP2.5 jum for human platelet test, respectively.
Results
Identification of Strain F-5408 Strain F-5408 was freshly isolated from a soil sample collected at the foot of Mt. Aso, Kumamoto Prefecture, Japan.
On potato dextrose agar, this strain formed slow-growing and dark olive gray colonies, attaining 1.5 cm in diameter after 2 weeks at 25°C. This colony surface was raised, felty, thick and tough. The reverse of the colony was pale yellow brown. Conidial structures were abundantly produced on the surface. Its conidiogenesis was holoblastic and conidiophores developed sympodially (Fig. 1) . The conidiophores were erect, straight or flexuose, smooth, pale brown, 55~100 /^m long and 2~3.5 /urn thick. They were simple or branched under septum, and the terminals of each branches formed conidia-producing denticulate portions, measuring 10~15 jum long. The conidia were solitary, dry, aseptate, reniform, smooth, brown and 4~5 x 3~3.5 /mi in size. On the basis of the morphological observations, strain F-5408 was assigned to the hyphomycete genus Virgaria Nees, described as monotypic. The above mentioned characteristics corresponded (1 liter). The column was washed with «-hexane and active compound was eluted with a mixture of w-hexane and ethyl acetate (1 : 2). Active fractions were combined and the organic solvent was removed by evaporation for further purification by repeated column chromatography on Lichroprep Si60 size B (E. Merck) with a mixture of chloroform and methanol (30 : 1) or n-hexane and ethyl acetate (1 : 1) respectively. Vinigrol was crystallized in a mixture of heptane and ethyl acetate. The yield was 445 mg.
Physico-chemical Properties of Vinigrol Vinigrol is soluble in chloroform, ethyl acetate, methanol and insoluble in water. Color reactions of vinigrol are as follows; positive to cerium sulfate, phosphomolybdic acid reagents, and negative to ninhydrin, Dragendorff, ferric chloride and Molisch reactions. The IR (CHC13) and *H NMR (400 MHz, CDC13)spectra are shown in Figs. 2 and 3 , respectively. The other physico-chemical properties of vinigrol are summarized in Table 1 . The molecular formula, C20H34O3, which was established from the elemental analysis and field desorption (FD) mass spectrum, indicated that vinigrol belong to a class of diterpenoid. The details of the chemical structure (Fig. 4 ) of this novel diterpene will be reported elsewhere in due course.
Effect on Arterial Blood Pressure and Heart Rate in Rats The effect of vinigrol on arterial blood pressure was evaluated intravenously in urethane (1 g/kg, ip) anesthetized normotensive SD rats. The result is summarized in Table 2 . Vinigrol reduced the systolic arterial blood pressure at 10~200 jug/kg and also decreased mean arterial blood pressure at 50~200 jug/kg in a dose-dependent manner. The effect of vinigrol (100^g/kg, iv) on mean arterial blood pressure and heart rate were estimated in a similar experiment and the result is shownin Table 3 . Vinigrol reduced both meanarterial blood pressure and heart rate to similar degrees. 
323(M+H)+
Effect on Rabbit and Human Platelet Aggregation The effect of vinigrol on rabbit and human platelet aggregation was estimated turbidimetrically. The IC50 values of vinigrol for several aggregation agents are summarized in Table 4 .
Fitr d Strnrtnrp. nf vinicrrol
Rabbit platelet was not aggregated with epinephrine alone, but was induced to aggregate with a combination of epinephrine and low concentration of ADP8).
Vinigrol inhibited the platelet aggregation induced with epinephrine or PAF. The IC50 values were 1.7x10"8m and 4.4x10"7m on rabbit platelet and 5.2x10~8m and 3.3x1O~8m on human platelet for each aggregation agent, respectively. Vinigrol did not show any inhibitory activity on ADP, thrombin and collagen induced rabbit platelet aggregation and neither revealed any inhibitory NT: Not tested. Table 3 . Effect of vinigrol on mean arterial blood pressure and heart rate in anesthetized SDrat. Vehicle; 10% PEG400 in 0.5 % methyl cellulose solution (1 ml/kg, iv). Vinigrol evoked aggregation of both rabbit and human platelet at higher concentrations. The minimumtolerated concentration for rabbit and human platelet was 6.2x10~6m and 3.1 x 10~6 m, respectively.
Other Biological Properties Antimicrobial activity of vinigrol was evaluated by the paper-disk diffusion assay. Vinigrol revealed a slight antimicrobial activity against Bacillus subtilis and Staphylococcus aureus at 10 mg/ml (growth inhibitory diameter was 12 mm), thrombin 0.5 u/ml, collagen 10^g/ml. Human; epinephrine 5^m, PAF 1.5 jum, ADP 2.5 jum.
but was not effective against Escherichia coli and Candida albicans at the same concentration. Vinigrol showedcytotoxic activity on P388 cultured cells in vitro at 10~50^g/ml. LD50 of vinigrol was 23 mg/kg (ip) when tested in ddY mice. JAN. 1988 Discussion Enzyme inhibitors, such as fusaric acid and oudenone which inhibited biosynthesis of catecholamines, have been identified as potent antihypertensive agents of microbial origin9).
Wepublished the discovery of several hypotensive vasodilators of microbial origin using a superfusion method of vascular smooth muscle preparation as a screening method2»3).
Vinigrol was isolated as a very potent antihypertensive agent through our screening program by measuring rat arterial blood pressure directly. Vinigrol inhibited the platelet aggregation induced by epinephrine and PAFspecifically at low concentration and provoked the platelet aggregation at higher concentration.
More detailed biochemical and pharmacological characterization will be described and discussed in the succeeding paper4) to clarify the biological profile of this unique compound.
